Global Blood Therapeutics: It Might Be Time To Buy The Dip

EzumeImages/iStock via Getty Images
The purpose of literature is to turn blood into ink. ― T.S. Eliot
Today, we take an in-depth look at Global Blood Therapeutics (GBT). The company has a new compound on the market targeting Sickle Cell Disease or SCD….

Click here to view the original article.